Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Some members may have coverage for FDA-approved options like Wegovy or Zepbound, often requiring prior authorization
Opportunity - Emerging Acute Therapies Present New Opportunities to Improve Outcomes in Ischemic Optic Neuropathy The absence of an approved acute therapy for ischemic optic neuropathy creates a significant unmet need in the global market
Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease
More on this story Published8 February 2022 Published11 February 2021 Published13 February 2023
These injectable therapies, often administered once weekly, provide sustained, controlled release, ensuring steady therapeutic effects with minimal intervention
